Hopkins researcher links gene mutation with poor outcomes in people with most common thyroid cancer
6th Jan 2006, 16:50 GMT
Scientists at Johns Hopkins have found that a mutation in the gene that triggers production of a tumor growth protein is linked to poorer outcomes for patients with papillary thyroid cancer (PTC). A report on the study is published in the December issue of The Journal of Clinical Endocrinology and Metabolism.
Hopkins researcher links gene mutation with poor outcomes in people with most common thyroid cancer related news:
- Hopkins Researcher Links Gene Mutation With Poor Outcomes In People With Most Common Thyroid Cancer — ScienceDaily Headlines: Health & Medicine
- Gene Mutation Linked To Poor Outcomes In People With Papillary Thyroid Cancer - Johns Hopkins — Medical News Today RSS/XML Feed
- Mutation linked to PTC has poorer outcomes — United Press International - NewsTrack
- Study finds genetic thyroid cancer link — United Press International - Health Business
- New Drug Lets Thyroid Cancer Patients Avoid Nasty Side Effects During Treatment, Johns Hopkins Study Shows — WebWire - Recent Headlines
- New drug lets thyroid cancer patients avoid nasty side effects during treatment — EurekAlert! - Breaking News
- rhTSH combined with radiation therapy successfully destroys remaining thyroid tissue — News-Medical News Feed
- Loss of gene linked to childhood cancer — HEALTH
- Loss of gene linked to spread of childhood cancer — Reuters: Health
- Coffee may lower some breast cancer risks — CTV News RSS Feed
Latest news from EurekAlert! - Medicine and Health:
- Enbrel provides sustained clinical improvements for ankylosing spondylitis for up to 3 years
- Enbrel first biologic with up to 9 years rheumatoid arthritis safety, sustained efficacy data
- UCSD computer scientist wins Young Investigator Award, research on snake venom proteins highlighted
- Why do insects like to eat some plants more than others?
- Opposites do not attract
- Wild gorillas carriers of an SIV virus close to the AIDS virus
- New data show ACTOS (pioglitazone HCl) halted progression of atherosclerosis as indicated by CIMT
- Pourquié lab identifies genes involved in formation of vertebral precursors
- Artificial cornea offers better results for infants, some blind patients
- Healthier kids just the click of a remote away